These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
768 related articles for article (PubMed ID: 15585614)
1. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients. Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614 [TBL] [Abstract][Full Text] [Related]
2. Quantitative molecular detection of minimal residual head and neck cancer in lymph node aspirates. Nieuwenhuis EJ; Jaspars LH; Castelijns JA; Bakker B; Wishaupt RG; Denkers F; Leemans CR; Snow GB; Brakenhoff RH Clin Cancer Res; 2003 Feb; 9(2):755-61. PubMed ID: 12576446 [TBL] [Abstract][Full Text] [Related]
3. Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction. Brakenhoff RH; Stroomer JG; ten Brink C; de Bree R; Weima SM; Snow GB; van Dongen GA Clin Cancer Res; 1999 Apr; 5(4):725-32. PubMed ID: 10213205 [TBL] [Abstract][Full Text] [Related]
4. Squamous cell carcinoma-associated antigens used in novel strategies for the detection and treatment of minimal residual head and neck cancer. van Dongen GA; Brakenhoff RM; ten Brink CT; van Gog FB; de Bree R; Quak JJ; Snow GB Anticancer Res; 1996; 16(4C):2409-13. PubMed ID: 8816843 [TBL] [Abstract][Full Text] [Related]
5. Detection of rare disseminated tumor cells identifies head and neck cancer patients at risk of treatment failure. Partridge M; Brakenhoff R; Phillips E; Ali K; Francis R; Hooper R; Lavery K; Brown A; Langdon J Clin Cancer Res; 2003 Nov; 9(14):5287-94. PubMed ID: 14614011 [TBL] [Abstract][Full Text] [Related]
6. Positive bone marrow biopsy is associated with a decreased disease-free survival in patients with operable breast cancer. Fortunato L; Mascaro A; Baldi A; Farina M; Cortese G; Ventrone MA; Amini M; Vitelli C Ann Surg Oncol; 2009 Nov; 16(11):3010-9. PubMed ID: 19641970 [TBL] [Abstract][Full Text] [Related]
7. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow. Weitz J; Kienle P; Magener A; Koch M; Schrödel A; Willeke F; Autschbach F; Lacroix J; Lehnert T; Herfarth C; von Knebel Doeberitz M Clin Cancer Res; 1999 Jul; 5(7):1830-6. PubMed ID: 10430088 [TBL] [Abstract][Full Text] [Related]
8. Molecular assay to detect metastatic head and neck squamous cell carcinoma. Becker MT; Shores CG; Yu KK; Yarbrough WG Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):21-7. PubMed ID: 14732763 [TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of a new molecular method for detection of micrometastases in head and neck squamous cell carcinoma. Shores CG; Yin X; Funkhouser W; Yarbrough W Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):937-42. PubMed ID: 15313863 [TBL] [Abstract][Full Text] [Related]
10. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695 [TBL] [Abstract][Full Text] [Related]
11. Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6D) quantitative reverse transcription-polymerase chain reaction. Nieuwenhuis EJ; Leemans CR; Kummer JA; Denkers F; Snow GB; Brakenhoff RH Lab Invest; 2003 Aug; 83(8):1233-40. PubMed ID: 12920252 [TBL] [Abstract][Full Text] [Related]
12. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level. Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789 [TBL] [Abstract][Full Text] [Related]
13. Distant metastases in head and neck carcinoma: identification of prognostic groups with MR imaging. Ljumanovic R; Langendijk JA; Hoekstra OS; Leemans CR; Castelijns JA Eur J Radiol; 2006 Oct; 60(1):58-66. PubMed ID: 16829010 [TBL] [Abstract][Full Text] [Related]
14. [Analysis of risk factors in the prediction of distant metastases of head and neck squamous cell carcinomas]. Li XM; Di B; Shang YD; Zhou YQ; Ma HM; Cheng JM Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Mar; 39(3):171-5. PubMed ID: 15283298 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of quantitative reverse transcription-polymerase chain reaction in lymph node-negative esophageal cancer patients. Godfrey TE; Raja S; Finkelstein SD; Gooding WE; Kelly LA; Luketich JD Clin Cancer Res; 2001 Dec; 7(12):4041-8. PubMed ID: 11751499 [TBL] [Abstract][Full Text] [Related]
16. Heparanase expression at the invasion front of human head and neck cancers and correlation with poor prognosis. Beckhove P; Helmke BM; Ziouta Y; Bucur M; Dörner W; Mogler C; Dyckhoff G; Herold-Mende C Clin Cancer Res; 2005 Apr; 11(8):2899-906. PubMed ID: 15837740 [TBL] [Abstract][Full Text] [Related]
17. Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease. Kufer P; Zippelius A; Lutterbüse R; Mecklenburg I; Enzmann T; Montag A; Weckermann D; Passlick B; Prang N; Reichardt P; Dugas M; Köllermann MW; Pantel K; Riethmüller G Cancer Res; 2002 Jan; 62(1):251-61. PubMed ID: 11782385 [TBL] [Abstract][Full Text] [Related]
18. [The current status of molecular detection of micrometastatic prostate cancer cells]. Deguchi T; Yang M; Yasuda M; Yokoi S; Nishino Y; Ehara H; Yamamoto N; Takahashi Y; Ishihara S Hinyokika Kiyo; 1999 Aug; 45(8):565-9. PubMed ID: 10500964 [TBL] [Abstract][Full Text] [Related]
19. [Molecular approach to detection of micrometastatic prostatic cancer cells in the lymph nodes and the bone marrow]. Deguchi T; Yang M; Nishino Y; Ehara H; Takahashi Y; Kawata Y; Ito S; Ito Y; Doi T Hinyokika Kiyo; 1996 Oct; 42(10):787-90. PubMed ID: 8951476 [TBL] [Abstract][Full Text] [Related]
20. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma. Katayama A; Ogino T; Bandoh N; Nonaka S; Harabuchi Y Clin Cancer Res; 2005 Apr; 11(8):2937-46. PubMed ID: 15837745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]